TIGER-PAC: Targeted Intra-arterial Gemcitabine vs Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer

Title
Targeted Intra-arterial Gemcitabine vs Continuation of IV Gemcitabine plus Nab-Paclitaxel following Induction with sequential IV Gemcitabine plus Nab-Paclitaxel and Radiotherapy for Unresectable Locally Advanced Pancreatic Cancer
Principal Investigator
Boone, Brian
Phase
III
Age Group
Adult
Applicable Disease Sites
Gastrointestinal Cancers
Participating Institutions
Mary Babb Randolph Cancer Center
Contacts
Meg Zafiris
Research Specialist
Email:

View on ClinicalTrials.gov